PortfoliosLab logoPortfoliosLab logo
NUTX vs. OKLO
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

NUTX vs. OKLO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nutex Health Inc (NUTX) and Oklo Inc. (OKLO). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NUTX vs. OKLO - Yearly Performance Comparison


2026 (YTD)2025202420232022
NUTX
Nutex Health Inc
-42.27%419.47%17.37%-90.53%-95.25%
OKLO
Oklo Inc.
-30.89%238.01%101.04%6.45%1.64%

Fundamentals

EPS

NUTX:

$14.78

OKLO:

-$0.73

Total Revenue (TTM)

NUTX:

$875.26M

OKLO:

$0.00

Gross Profit (TTM)

NUTX:

$444.28M

OKLO:

$0.00

EBITDA (TTM)

NUTX:

$274.31M

OKLO:

-$138.92M

Returns By Period

In the year-to-date period, NUTX achieves a -42.27% return, which is significantly lower than OKLO's -30.89% return.


NUTX

1D
4.55%
1M
-13.96%
YTD
-42.27%
6M
-8.01%
1Y
102.08%
3Y*
-14.40%
5Y*
10Y*

OKLO

1D
8.80%
1M
-21.22%
YTD
-30.89%
6M
-55.58%
1Y
129.26%
3Y*
69.68%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NUTX vs. OKLO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NUTX
NUTX Risk / Return Rank: 7272
Overall Rank
NUTX Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
NUTX Sortino Ratio Rank: 7979
Sortino Ratio Rank
NUTX Omega Ratio Rank: 7474
Omega Ratio Rank
NUTX Calmar Ratio Rank: 7272
Calmar Ratio Rank
NUTX Martin Ratio Rank: 6464
Martin Ratio Rank

OKLO
OKLO Risk / Return Rank: 7676
Overall Rank
OKLO Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
OKLO Sortino Ratio Rank: 8383
Sortino Ratio Rank
OKLO Omega Ratio Rank: 7575
Omega Ratio Rank
OKLO Calmar Ratio Rank: 7474
Calmar Ratio Rank
OKLO Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NUTX vs. OKLO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nutex Health Inc (NUTX) and Oklo Inc. (OKLO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NUTXOKLODifference

Sharpe ratio

Return per unit of total volatility

0.88

1.21

-0.33

Sortino ratio

Return per unit of downside risk

1.99

2.21

-0.23

Omega ratio

Gain probability vs. loss probability

1.24

1.24

-0.01

Calmar ratio

Return relative to maximum drawdown

1.54

1.65

-0.10

Martin ratio

Return relative to average drawdown

2.40

3.39

-0.98

NUTX vs. OKLO - Sharpe Ratio Comparison

The current NUTX Sharpe Ratio is 0.88, which is comparable to the OKLO Sharpe Ratio of 1.21. The chart below compares the historical Sharpe Ratios of NUTX and OKLO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NUTXOKLODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.88

1.21

-0.33

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.48

0.48

-0.96

Correlation

The correlation between NUTX and OKLO is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

NUTX vs. OKLO - Dividend Comparison

Neither NUTX nor OKLO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NUTX vs. OKLO - Drawdown Comparison

The maximum NUTX drawdown since its inception was -99.93%, which is greater than OKLO's maximum drawdown of -73.83%. Use the drawdown chart below to compare losses from any high point for NUTX and OKLO.


Loading graphics...

Drawdown Indicators


NUTXOKLODifference

Max Drawdown

Largest peak-to-trough decline

-99.93%

-73.83%

-26.10%

Max Drawdown (1Y)

Largest decline over 1 year

-54.34%

-73.83%

+19.49%

Current Drawdown

Current decline from peak

-98.42%

-71.52%

-26.90%

Average Drawdown

Average peak-to-trough decline

-97.24%

-16.20%

-81.04%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.90%

35.87%

-0.97%

Volatility

NUTX vs. OKLO - Volatility Comparison

Nutex Health Inc (NUTX) has a higher volatility of 24.94% compared to Oklo Inc. (OKLO) at 21.29%. This indicates that NUTX's price experiences larger fluctuations and is considered to be riskier than OKLO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NUTXOKLODifference

Volatility (1M)

Calculated over the trailing 1-month period

24.94%

21.29%

+3.65%

Volatility (6M)

Calculated over the trailing 6-month period

73.87%

70.69%

+3.18%

Volatility (1Y)

Calculated over the trailing 1-year period

116.41%

107.15%

+9.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

135.16%

84.92%

+50.24%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

135.16%

84.92%

+50.24%

Financials

NUTX vs. OKLO - Financials Comparison

This section allows you to compare key financial metrics between Nutex Health Inc and Oklo Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
151.68M
0
(NUTX) Total Revenue
(OKLO) Total Revenue
Values in USD except per share items